Biological agents for rheumatoid arthritis: targeting both physical function and structural damage.
about
Advances in rheumatology: new targeted therapeuticsDeficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthmaDevelopment of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patientsCost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain.Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.Anti-inflammatory and anti-arthritic activity of a methanol extract from Vitellaria paradoxa stem bark.TNFalpha blockade in human diseases: mechanisms and future directions.A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response.Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.Pulmonary complications of tumor necrosis factor-targeted therapy.Adalimumab (TNF α Inhibitor) Therapy Exacerbates IgA Glomerulonephritis Acute Renal Injury and Induces Lupus Autoantibodies in a Psoriasis Patient.Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.Pulmonary implications in inflammatory bowel disease: not a rare event.Evaluation of analgesic and anti-inflammatory activity of Bridelia retusa (Spreng) barkA possible mechanism for hepatotoxicity induced by BIRB-796, an orally active p38 mitogen-activated protein kinase inhibitor.Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (β-lapachone).Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study.Tumor necrosis factor-alpha antagonists: differential clinical effects by different biotechnological molecules
P2860
Q21093257-292FB59D-3E01-4562-8974-C1397F6F9D0BQ34154042-6320B628-00A0-4519-AE25-BDCFD71FA1DCQ34556944-F358AA0A-605F-4E88-A472-60A1C24A9E3CQ35138666-C26FC91C-FF24-4D41-A0C9-9870C0433FC2Q35795354-92244611-1C01-4EF3-8960-4B8EA13707BEQ36052572-D339655C-DCE5-431F-A2B4-1A31A2A5802BQ36321179-A1C28072-76C7-4269-A44C-359DF67C4AD0Q36536886-3EDFFE5C-3316-430F-A85F-6E53A94C30F1Q36654727-8877841D-133E-438C-90EC-7A6E80D4F501Q36779299-C93251C7-9168-440E-BA2B-435431DE5D42Q37345155-82F6020A-8CA4-459B-860E-1BE1FC0FAB5BQ37556070-3BB305B3-9E33-4D8C-A074-32EEB5D09F8FQ38008692-3CFC2A7A-B067-4ECB-8FA9-FC07AA625565Q40750800-DF7BCC32-7134-4C01-8581-C22A57067AE7Q42374035-98D3A006-8CDF-4AC5-A822-ADB5A8F4ABD5Q42750295-CB97C58E-01FB-4568-B14E-152016EF9585Q45248130-BCE2B747-218A-4665-8548-223E06DE6412Q47650717-71DCED49-7169-40F6-AA5C-11A2B4DE550AQ56990581-C10DB4A7-B0B4-4374-8BAD-1DE6F0C330E8
P2860
Biological agents for rheumatoid arthritis: targeting both physical function and structural damage.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biological agents for rheumato ...... unction and structural damage.
@ast
Biological agents for rheumato ...... unction and structural damage.
@en
type
label
Biological agents for rheumato ...... unction and structural damage.
@ast
Biological agents for rheumato ...... unction and structural damage.
@en
prefLabel
Biological agents for rheumato ...... unction and structural damage.
@ast
Biological agents for rheumato ...... unction and structural damage.
@en
P1433
P1476
Biological agents for rheumato ...... unction and structural damage.
@en
P2093
Alice Klinkhoff
P304
P356
10.2165/00003495-200464120-00001
P577
2004-01-01T00:00:00Z
P6179
1017960585